SCIENCE IN THE NEWS DAILY
Stem Cell Study May Show Advance
from the New York Times (Registration Required)
LOS ANGELES -- A treatment for eye diseases that is derived from human embryonic stem cells might have improved the vision of two patients, bolstering the beleaguered field, researchers reported Monday.
The report, published online in the medical journal The Lancet, is the first to describe the effect on patients of a therapy involving human embryonic stem cells.
The paper comes two months after Geron Corporation, a stem cell industry pioneer, cast a pall over the field by abruptly halting the world's first clinical trial based on embryonic stem cells--one aimed at treating spinal cord injury. Geron, which has not published results from the aborted trial, also said it would abandon the entire stem cell field.
Read more...
Science in the Media
Newspapers:
Magazines and Web Sites:
The Science-Media Intersection:
Subscribe to Our Content!
Visit our RSS Feeds page to choose among 13 customized feeds, or create a free My AmSci account to request an email notice whenever a specified author, department or discipline appears online.